{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:01:45Z","timestamp":1780016505876,"version":"3.53.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Program of Zhejiang Province"},{"name":"the Key Project of the Zhejiang Medical and Health Major Science and Technology Plan"},{"name":"the Traditional Chinese Medicine Science and Technology Program of Zhejiang Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46594-8","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:16:58Z","timestamp":1775636218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isoliquiritigenin alleviates ulcerative colitis by enhancing the intestinal barrier and improving intestinal microbiota via inhibiting the TLR4\/MyD88\/NF-\u03baB pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruifang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drolma","family":"Kelsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanhui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"46594_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L. & Colombel, J. F. Ulcerative colitis. Lancet 389, 1756\u20131770 (2017).","journal-title":"Lancet"},{"key":"46594_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/cells8020193","volume":"8","author":"I Schoultz","year":"2019","unstructured":"Schoultz, I. & Keita, \u00c5. V. Cellular and molecular therapeutic targets in inflammatory bowel disease\u2014focusing on intestinal barrier function. Cells 8, 193 (2019).","journal-title":"Cells"},{"key":"46594_CR3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2020.10.259","volume":"166","author":"L Cui","year":"2021","unstructured":"Cui, L. et al. Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. Int. J. Biol. Macromol. 166, 1035\u20131045 (2021).","journal-title":"Int. J. Biol. Macromol."},{"key":"46594_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre, C. & Honap, S. Peyrin-Biroulet, L. Ulcerative colitis. Lancet 402, 571\u2013584 (2023).","journal-title":"Lancet"},{"key":"46594_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cyto.2016.04.012","volume":"83","author":"YT Xiao","year":"2016","unstructured":"Xiao, Y. T., Yan, W. H., Cao, Y., Yan, J. K. & Cai, W. Neutralization of IL-6 and TNF-\u03b1 ameliorates intestinal permeability in DSS-induced colitis. Cytokine 83, 189\u2013192 (2016).","journal-title":"Cytokine"},{"key":"46594_CR6","doi-asserted-by":"publisher","first-page":"109847","DOI":"10.1016\/j.biopha.2020.109847","volume":"124","author":"YD Jeon","year":"2020","unstructured":"Jeon, Y. D., Lee, J. H., Lee, Y. M. & Kim, D. K. Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model. Biomed. Pharmacother. 124, 109847 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"46594_CR7","doi-asserted-by":"publisher","first-page":"119008","DOI":"10.1016\/j.lfs.2020.119008","volume":"269","author":"B Li","year":"2021","unstructured":"Li, B. et al. Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats. Life Sci. 269, 119008 (2021).","journal-title":"Life Sci."},{"key":"46594_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/08923973.2018.1469145","volume":"40","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Tang, Q., Duan, P. & Yang, L. Curcumin as a therapeutic agent for blocking NF-\u03baB activation in ulcerative colitis. Immunopharmacol. Immunotoxicol. 40, 476\u2013482 (2018).","journal-title":"Immunopharmacol. Immunotoxicol"},{"key":"46594_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12967-023-04687-2","volume":"21","author":"J Wei","year":"2023","unstructured":"Wei, J. et al. Muc2 mucin O-glycosylation interacts with enteropathogenic escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway. J. Transl Med. 21, 793 (2023).","journal-title":"J. Transl Med."},{"key":"46594_CR10","doi-asserted-by":"publisher","first-page":"108904","DOI":"10.1016\/j.intimp.2022.108904","volume":"109","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4\/NF-\u03baB signaling pathways. Int. Immunopharmacol. 109, 108904 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"46594_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.intimp.2018.09.025","volume":"64","author":"C Cao","year":"2018","unstructured":"Cao, C. et al. Ulinastatin mediates suppression of regulatory T cells through TLR4\/NF-\u03baB signaling pathway in murine sepsis. Int. Immunopharmacol. 64, 411\u2013423 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"46594_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/kjm2.12400","volume":"37","author":"LH Hu","year":"2021","unstructured":"Hu, L. H., Liu, J. Y. & Yin, J. B. Eriodictyol attenuates TNBS-induced ulcerative colitis through repressing TLR4\/NF-kB signaling pathway in rats. Kaohsiung J. Med. Sci. 37, 812\u2013818 (2021).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"46594_CR13","doi-asserted-by":"crossref","unstructured":"Qi, J. et al. Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression. Cardiovasc. Ther. 1\u20138 (2020). (2020).","DOI":"10.1155\/2020\/1926249"},{"key":"46594_CR14","doi-asserted-by":"publisher","first-page":"e4521","DOI":"10.1002\/bmc.4521","volume":"33","author":"Y Shen","year":"2019","unstructured":"Shen, Y., Cui, X., Jiang, S., Qian, D. & Duan, J. Comparative pharmacokinetics of nine major bioactive components in normal and ulcerative colitis rats after oral administration of Lizhong decoction extracts by UPLC\u2013TQ\u2013MS\/MS. Biomed. Chromatogr. 33, e4521 (2019).","journal-title":"Biomed. Chromatogr."},{"key":"46594_CR15","doi-asserted-by":"crossref","unstructured":"Xu, X. et al. Simultaneous Determination of Ten Bioactive Components from Shenling Baizhu San in Rat Plasma by UHPLC-MS\/MS: Application to a comparative pharmacokinetic study in normal and two models of ulcerative colitis rats. Evid-based. Compl. Alt. 1\u201315 (2021).","DOI":"10.1155\/2021\/3518241"},{"key":"46594_CR16","doi-asserted-by":"publisher","first-page":"981055","DOI":"10.3389\/fchem.2022.981055","volume":"10","author":"M Xiao","year":"2022","unstructured":"Xiao, M. et al. Colon-specific delivery of isoliquiritigenin by oral edible zein\/caseate nanocomplex for ulcerative colitis treatment. Front. Chem. 10, 981055 (2022).","journal-title":"Front. Chem."},{"key":"46594_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.xphs.2023.09.020","volume":"113","author":"F Shi","year":"2024","unstructured":"Shi, F. et al. Isoliquiritigenin containing PH sensitive micelles for enhanced anti-colitis activity. J. Pharm. Sci. 113, 918\u2013929 (2024).","journal-title":"J. Pharm. Sci."},{"key":"46594_CR18","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.2174\/0929867325666181112091700","volume":"26","author":"TT Zhao","year":"2019","unstructured":"Zhao, T. T., Xu, Y. Q., Hu, H. M., Gong, H. B. & Zhu, H. L. Isoliquiritigenin (ISL) and its formulations: Potential antitumor agents. Curr. Med. Chem. 26, 6786\u20136796 (2019).","journal-title":"Curr. Med. Chem."},{"key":"46594_CR19","doi-asserted-by":"publisher","first-page":"2101119","DOI":"10.1002\/mnfr.202101119","volume":"66","author":"R Ishibashi","year":"2022","unstructured":"Ishibashi, R. et al. Isoliquiritigenin attenuates adipose tissue inflammation and metabolic syndrome by modifying gut bacteria composition in mice. Mol. Nutr. Food Res. 66, 2101119 (2022).","journal-title":"Mol. Nutr. Food Res."},{"key":"46594_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fnagi.2018.00348","volume":"10","author":"M Ramalingam","year":"2018","unstructured":"Ramalingam, M., Kim, H., Lee, Y. & Lee, Y. I. Phytochemical and pharmacological role of liquiritigenin and isoliquiritigenin from Radix Glycyrrhizae in human health and disease models. Front. Aging Neurosci. 10, 348 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"46594_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jbcpp-2018-0036","volume":"30","author":"N Tatiya-Aphiradee","year":"2018","unstructured":"Tatiya-Aphiradee, N., Chatuphonprasert, W. & Jarukamjorn, K. Immune response and inflammatory pathway of ulcerative colitis. J. Basic. Clin. Physiol. Pharmacol. 30, 1\u201310 (2018).","journal-title":"J. Basic. Clin. Physiol. Pharmacol."},{"key":"46594_CR22","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk, P., Yeshi, K. & Loukas, A. Ulcerative colitis: Clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol. Sci. 45, 892\u2013903 (2024).","journal-title":"Trends Pharmacol. Sci."},{"key":"46594_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano, T. IL-6 in inflammation, autoimmunity and cancer. Int. Immunol. 33, 127\u2013148 (2021).","journal-title":"Int. Immunol."},{"key":"46594_CR24","doi-asserted-by":"crossref","unstructured":"Bing, X., Xuelei, L., Wanwei, D., Linlang, L. & Keyan, C. EGCG Maintains Th1\/Th2 balance and mitigates ulcerative colitis induced by dextran sulfate sodium through TLR4\/MyD88\/NF-\u03baB signaling pathway in rats. Can J Gastroenterol Hepatol 3057268 (2017). (2017).","DOI":"10.1155\/2017\/3057268"},{"key":"46594_CR25","doi-asserted-by":"publisher","first-page":"674416","DOI":"10.3389\/fphar.2021.674416","volume":"12","author":"Q Yang","year":"2021","unstructured":"Yang, Q. et al. Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4\/MyD88\/NF-\u03baB Signaling Pathway and Gut Microbiota. Front. Pharmacol. 12, 674416 (2021).","journal-title":"Front. Pharmacol."},{"key":"46594_CR26","doi-asserted-by":"crossref","unstructured":"Niu, S. et al. Jatrorrhizine alleviates DSS-induced ulcerative colitis by regulating the intestinal barrier function and inhibiting TLR4\/MyD88\/NF-\u03baB signaling pathway. Evid Based Complement Alternat Med 3498310 (2022).","DOI":"10.1155\/2022\/3498310"},{"key":"46594_CR27","doi-asserted-by":"publisher","first-page":"767456","DOI":"10.3389\/fimmu.2021.767456","volume":"12","author":"LW Kaminsky","year":"2021","unstructured":"Kaminsky, L. W., Al-Sadi, R. & Ma, T. Y. IL-1\u03b2 and the intestinal epithelial tight junction barrier. Front. Immunol. 12, 767456 (2021).","journal-title":"Front. Immunol."},{"key":"46594_CR28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/ecco-jcc\/jjx075","volume":"11","author":"W Stremmel","year":"2017","unstructured":"Stremmel, W. et al. Genetic mouse models with intestinal-specific tight junction deletion resemble an Ulcerative Colitis phenotype. J. Crohns Colitis. 11, 1247\u20131257 (2017).","journal-title":"J. Crohns Colitis"},{"key":"46594_CR29","doi-asserted-by":"publisher","first-page":"e1463897","DOI":"10.1080\/21688370.2018.1463897","volume":"6","author":"AN Anbazhagan","year":"2018","unstructured":"Anbazhagan, A. N., Priyamvada, S., Alrefai, W. A. & Dudeja, P. K. Pathophysiology of IBD associated diarrhea. Tissue Barriers. 6, e1463897 (2018).","journal-title":"Tissue Barriers"},{"key":"46594_CR30","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1136\/gutjnl-2023-329964","volume":"72","author":"MF Neurath","year":"2023","unstructured":"Neurath, M. F. & Vieth, M. Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing. Gut 72, 2164\u20132183 (2023).","journal-title":"Gut"},{"key":"46594_CR31","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.3390\/ijms22147618","volume":"22","author":"A Saez","year":"2021","unstructured":"Saez, A. et al. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int. J. Mol. Sci. 22, 7618 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"46594_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/gutjnl-2015-309990","volume":"65","author":"JR Marchesi","year":"2016","unstructured":"Marchesi, J. R. et al. The gut microbiota and host health: a new clinical frontier. Gut 65, 330\u2013339 (2016).","journal-title":"Gut"},{"key":"46594_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang, Y. Z. Inflammatory bowel disease: pathogenesis. World J. Gastroenterol. 20, 91 (2014).","journal-title":"World J. Gastroenterol."},{"key":"46594_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","volume":"13","author":"A Geremia","year":"2014","unstructured":"Geremia, A., Biancheri, P., Allan, P., Corazza, G. R. & Di Sabatino, A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun. Rev. 13, 3\u201310 (2014).","journal-title":"Autoimmun. Rev."},{"key":"46594_CR35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3892\/etm.2021.10757","volume":"22","author":"ZF Dai","year":"2021","unstructured":"Dai, Z. F. et al. Intestinal flora alterations in patients with ulcerative colitis and their association with inflammation. Exp. Ther. Med. 22, 1322 (2021).","journal-title":"Exp. Ther. Med."},{"key":"46594_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/19490976.2017.1290757","volume":"8","author":"AR Weingarden","year":"2017","unstructured":"Weingarden, A. R. & Vaughn, B. P. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes. 8, 238\u2013252 (2017).","journal-title":"Gut Microbes"},{"key":"46594_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/15548627.2019.1635384","volume":"16","author":"A Larabi","year":"2020","unstructured":"Larabi, A., Barnich, N. & Nguyen, H. T. T. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy 16, 38\u201351 (2020).","journal-title":"Autophagy"},{"key":"46594_CR38","doi-asserted-by":"publisher","first-page":"921546","DOI":"10.3389\/fimmu.2022.921546","volume":"13","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Two-sample mendelian randomization analysis investigates causal associations between gut microbial genera and inflammatory bowel disease, and specificity causal associations in ulcerative Colitis or Crohn\u2019s Disease. Front. Immunol. 13, 921546 (2022).","journal-title":"Front. Immunol."},{"key":"46594_CR39","doi-asserted-by":"publisher","first-page":"107194","DOI":"10.1016\/j.phrs.2024.107194","volume":"204","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Baicalin restore intestinal damage after early-life antibiotic therapy: the role of the MAPK signaling pathway. Pharmacol. Res. 204, 107194 (2024).","journal-title":"Pharmacol. Res."},{"key":"46594_CR40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann, E. R., Lam, Y. K. & Uhlig, H. H. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat. Rev. Immunol. 24, 577\u2013595 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"46594_CR41","doi-asserted-by":"publisher","first-page":"733992","DOI":"10.3389\/fcimb.2022.733992","volume":"12","author":"P Qiu","year":"2022","unstructured":"Qiu, P. et al. The Gut Microbiota in Inflammatory Bowel Disease. Front. Cell. Infect. Microbiol. 12, 733992 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"46594_CR42","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/j.1365-2036.2006.02927.x","volume":"23","author":"MA Zocco","year":"2006","unstructured":"Zocco, M. A. et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharm. Ther. 23, 1567\u20131574 (2006).","journal-title":"Aliment. Pharm. Ther."},{"key":"46594_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clnesp.2022.08.020","volume":"51","author":"LM Agraib","year":"2022","unstructured":"Agraib, L. M., Yamani, M. I., Tayyem, R., Abu-Sneineh, A. T. & Rayyan, Y. M. Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study. Clin. Nutr. ESPEN. 51, 83\u201391 (2022).","journal-title":"Clin. Nutr. ESPEN"},{"key":"46594_CR44","doi-asserted-by":"publisher","first-page":"104978","DOI":"10.1016\/j.phrs.2020.104978","volume":"159","author":"MX Wang","year":"2020","unstructured":"Wang, M. X. et al. Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production. Pharmacol. Res. 159, 104978 (2020).","journal-title":"Pharmacol. Res."},{"key":"46594_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1751-2980.12849","volume":"21","author":"XY Guo","year":"2020","unstructured":"Guo, X. Y., Liu, X. J. & Hao, J. Y. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment. J. Dig. Dis. 21, 147\u2013159 (2020).","journal-title":"J. Dig. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46594-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46594-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46594-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:03:26Z","timestamp":1780013006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46594-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46594"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46594-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed following the Guide for the Care and Use of Laboratory Animals of Zhejiang University of Technology and were approved by the Laboratory Animal Welfare and Ethics Committee (Approval number: ZH20230705003). All methods are reported in accordance with ARRIVE guidelines (\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"16605"}}